NDC 68788-7697-01 - levothyroxine sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68788-7697
- Requested NDC
- 68788-7697-01
- Package NDCs from labels
- 68788-7697-3, 68788-7697-9, 68788-7697-1, 68788-7697-01
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Effective date
- 2026-01-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| levothyroxine sodium - Preferred Pharmaceuticals, Inc. | Preferred Pharmaceuticals, Inc. | 2026-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68788-7697-1 | levothyroxine sodium | 100 in 1 BOTTLE | TABLET | 100 | 7 | |
| 68788-7697-3 | levothyroxine sodium | 30 in 1 BOTTLE | TABLET | 30 | 7 | |
| 68788-7697-9 | levothyroxine sodium | 90 in 1 BOTTLE | TABLET | 90 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68788-7697 | LEVOTHYROXINE SODIUM TABLET [PREFERRED PHARMACEUTICALS, INC.] | 5 | Current NDC, Legacy NDC, 3 package rows | 20240415_579b1935-77f5-4381-9cb0-e0130e4834e8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68788-7697-1 | EA - Each | 68788-7697 | 383e850c-126a-4f04-ad7a-02719c8103bb | 1 | 2020-07-13 |
| 68788-7697-3 | EA - Each | 68788-7697 | c0409d97-4592-4717-bced-0111d6a97121 | 1 | 2020-07-13 |
| 68788-7697-9 | EA - Each | 68788-7697 | 4c188ae3-d15c-4d74-9d33-d7e8437a0007 | 1 | 2020-07-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 66bb0ba9-cd63-4817-907f-7b8ad5dc6685 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 966248 9J765S329G |
| Tirosint SOL | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 5d378add-f13d-40f2-99dc-0f2340ab44b7 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | a0fa8fa5-d3bd-4e52-9ec5-5fb84702826d | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 70853a82-ba3b-4663-9f78-6791ca72ba9f | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 8ac112c3-1e06-4fdb-a7af-2ee988de5b15 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 69fb5cd6-90ba-487d-a754-07c664a1fdd1 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Tirosint | LEVOTHYROXINE SODIUM | IBSA Pharma Inc. | 7a7ade79-0165-4e31-b84e-667416c00c7e | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | YARAL Pharma Inc. | d28d7202-1278-0486-e053-2995a90af286 | 2026-03-25 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 7c8a6441-3c12-46ae-bb3b-a320d80045b6 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 008de8fd-150f-4022-8ccb-c8bfa94875c7 | 2026-03-24 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 991399a4-ff94-44d0-b1ba-1f89e7759498 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 87333260-fe57-4d99-886c-7c66cb063898 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 52a07ade-4098-477d-874e-dd692667041e | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Leader Advanced Relief Eye Drops | DEXTRAN 70, POLYETHYLENE GLYCOL 400, POVIDONE, TETRAHYDROZOLINE HCL | Cardinal Health | 5c5d6c13-9b51-48f0-8627-b60b0f707fd3 | 2026-03-12 | Warnings | FZ989GH94E |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 67f46137-afc4-471b-a6c7-9c2aef92da5d | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 70a9bb5c-2259-405e-8d89-cc1db8c70743 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | PD-Rx Pharmaceuticals, Inc. | 6f4998ac-0714-4f5d-8944-9e6902b9f0a6 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 853d9e86-2b5b-4967-8c22-70ad34f03418 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | A-S Medication Solutions | b42fe9dd-8383-4839-9eab-393de388da71 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | fa7dd488-de7e-4f9e-87db-18391b723aad | 2026-02-19 | Boxed warning, Warnings, Adverse reactions | 9J765S329G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.